SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-019292
Filing Date
2022-04-12
Accepted
2022-04-12 08:00:30
Documents
152
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2021_altamirathera.htm   iXBRL 20-F 3435009
2 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE EXCHANGE ACT f20f2021ex2-13_altamira.htm EX-2.13 117785
3 LIST OF SUBSIDIARIES f20f2021ex8-1_altamira.htm EX-8.1 3082
4 CERTIFICATION f20f2021ex12-1_altamira.htm EX-12.1 9512
5 CERTIFICATION f20f2021ex12-2_altamira.htm EX-12.2 9479
6 CERTIFICATION f20f2021ex13-1_altamira.htm EX-13.1 3579
7 CERTIFICATION f20f2021ex13-2_altamira.htm EX-13.2 3568
8 CONSENT OF DELOITTE AG f20f2021ex15-1_altamira.htm EX-15.1 2573
9 GRAPHIC image_001.jpg GRAPHIC 7738
  Complete submission text file 0001213900-22-019292.txt   13595503

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE cyto-20211231.xsd EX-101.SCH 194456
11 XBRL CALCULATION FILE cyto-20211231_cal.xml EX-101.CAL 36535
12 XBRL DEFINITION FILE cyto-20211231_def.xml EX-101.DEF 477628
13 XBRL LABEL FILE cyto-20211231_lab.xml EX-101.LAB 987832
14 XBRL PRESENTATION FILE cyto-20211231_pre.xml EX-101.PRE 503334
146 EXTRACTED XBRL INSTANCE DOCUMENT f20f2021_altamirathera_htm.xml XML 2376208
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36582 | Film No.: 22821115
SIC: 2834 Pharmaceutical Preparations